19 results
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
securities that are convertible into or exercisable for Tyme’s common stock in connection with hiring or retaining employees, future acquisitions, future … and expanding Tyme’s portfolio of IP rights, including patents, trade secrets and know-how; and
attracting, hiring and retaining qualified personnel
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
securities that are convertible into or exercisable for Tyme’s common stock in connection with hiring or retaining employees, future acquisitions, future … ;
maintaining, protecting and expanding Tyme’s portfolio of IP rights, including patents, trade secrets andknow-how;
and
attracting, hiring
8-K
SYRS
Syros Pharmaceuticals Inc.
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
of Principal Officers.
On October 12, 2021, we announced the hiring and appointment of Jason Haas as the Chief Financial Officer of Syros
8-K
EX-10.1
pxbikac
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
8-K
EX-2.1
3soosk cda
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
10-K
qclasmy
20 Mar 17
Annual report
12:00am
10-K
EX-10.13
dcjzo6v
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next